Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107099516A details high-efficiency enzymatic UDCA production. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel hydrophilic surfactants derived from renewable chitin. Improved solubility and surface tension control for pharma and cosmetic applications via patented synthesis.
Patent CN114957170A reveals a cost-effective copper-catalyzed monofluoroolefination method offering superior Z-selectivity for reliable pharmaceutical intermediate manufacturing.
Patent CN1119332C details a novel asymmetric hydrogenation route for azepine intermediates, offering cost-effective and scalable production for kinase inhibitors like Balanol.
Patent CN106755254B details a mild enzymatic route for lipoic acid sterol ester, offering high purity and yield for food and pharma applications.
Patent CN106701698A reveals high-efficiency enzymatic synthesis for chiral alcohols. Offers cost reduction and high purity for pharmaceutical supply chains.
Patent CN108546691A details a novel 7β-HSDH mutant using NADH for cost-effective ursodeoxycholic acid production with high purity and yield.
Patent CN101675020A details a novel asymmetric hydrogenation method for high-purity optically active aldehydes like citronellal, offering enhanced catalyst stability and supply chain reliability.
Novel PTC-catalyzed oxidation of 3,5-lutidine yields high-purity 5-methylnicotinic acid. Reduces water usage and boosts efficiency for Rupatadine manufacturing.
Patent CN1166620C details green nitration using perfluoroalkanesulfonic acid salts, offering cost reduction and high purity for industrial scale-up.
Novel Aeromonas caviae B18 strain enables high-purity chiral intermediate production with reduced costs and simplified downstream processing for pharma.
Patent CN104789505B reveals enzymatic route for high purity statin intermediates. Offers cost reduction and supply reliability for pharmaceutical manufacturing.
Patent CN1269950C details a novel biotechnological process for preparing amides using Amycolatopsis and Rhodococcus strains, offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN1220695A details a microbial process for chiral aminoalcohols, offering a scalable alternative to chemical synthesis for carbocyclic nucleosides.
Patent CN113292517A reveals a mild anion exchange resin method for shikimic acid epoxide synthesis, offering 98-100% yield and enhanced supply chain safety.
Patent CN110357907B reveals a recyclable copper complex for efficient Mannich reactions at room temperature, offering significant cost and purity advantages.
Patent CN108300744A reveals enzymatic synthesis for high purity D-heterocyclic amino acids. This technology reduces cost and improves supply chain reliability for global pharmaceutical buyers seeking scalable intermediates.
Patent CN106187840B reveals a stable method for trifluoromethylthio indanone synthesis. This report analyzes cost reduction and supply chain reliability for global buyers.
Novel morpholine-indole base system enhances Fmoc-Osu yield and purity. Reduces purification complexity for reliable pharmaceutical intermediate supply chains.
Advanced biocatalytic method for high-purity nicotinamide. Reduces costs and improves supply chain reliability for pharmaceutical and feed industries globally.